Explore 3 Stock Ideas & Industry Insights Download Free Report

18889881171
Shopping Cart 0
countryflagUS
Login

Extendicare Inc

Healthcare CA EXE

31.73CAD
1.02(3.32%)

Last update at 2026-06-03T20:00:00Z

Day Range

30.6032.06
LowHigh

52 Week Range

11.9029.99
LowHigh

Fundamentals

  • Previous Close 30.71
  • Market Cap2642.93M
  • Volume539545
  • P/E Ratio25.21
  • Dividend Yield1.74%
  • EBITDA150.59M
  • Revenue TTM1660.41M
  • Revenue Per Share TTM19.44
  • Gross Profit TTM 236.84M
  • Diluted EPS TTM1.11

Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website

Analyst Recommendations

Financials

Income Statement

Balance Sheet

Change in Cash

Total Operating Cash

Dividends Paid

Breakdown 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Type yearly yearly yearly yearly yearly
Date 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Income before tax 130.10M 99.86M 44.80M -4.49600M 16.04M
Minority interest - - - - -
Net income 96.66M 75.21M 33.98M -4.51100M 9.01M
Selling general administrative 1357.88M 1199.50M 55.84M 1164.12M 1140.20M
Selling and marketing expenses - - 1032.78M - -
Gross profit 199.59M 168.00M 167.62M 1221.58M 1216.76M
Reconciled depreciation 36.94M 33.34M 32.23M 32.12M 38.57M
Ebit 138.37M 121.94M 66.41M 20.99M 56.62M
Ebitda 175.61M 155.27M 98.63M 53.11M 95.19M
Depreciation and amortization 37.25M 33.34M 32.23M 32.12M 38.57M
Non operating income net other - - - - -
Operating income 138.37M 111.21M 62.96M 20.99M 56.62M
Other operating expenses 1522.04M 1354.99M 1242.37M 1196.91M 1162.01M
Interest expense 19.23M 21.10M 21.60M 20.61M 27.20M
Tax provision 33.45M 24.65M 10.82M 0.01M 7.03M
Interest income 5.73M 13.11M 6.19M 15.52M 23.74M
Net interest income -13.80300M -15.73500M -15.49300M -15.28200M -25.03200M
Extraordinary items - - 0.00000M 74.06M 2.49M
Non recurring - - - - -
Other items - - - - -
Income tax expense 33.45M 24.65M 10.82M 0.01M 7.03M
Total revenue 1660.41M 1466.20M 1304.96M 1221.58M 1216.76M
Total operating expenses 61.22M 56.94M 55.84M 1196.91M 1162.01M
Cost of revenue 1460.82M 1298.21M 1137.34M 1113.05M 1070.41M
Total other income expense net -8.26300M -11.35200M -18.15900M -25.48300M -40.58000M
Discontinued operations - - - 74.06M 2.49M
Net income from continuing ops 96.66M 75.21M 33.98M -4.51100M 9.01M
Net income applicable to common shares - 75.21M 33.98M 69.55M 11.50M
Preferred stock and other adjustments - - - - -
Breakdown 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Type yearly yearly yearly yearly yearly
Date 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Total assets 1066.52M 719.79M 672.73M 781.58M 900.32M
Intangible assets 103.07M 75.06M 78.46M 51.21M 46.63M
Earning assets - - - - -
Other current assets 17.58M 28.82M 20.20M 23.98M 26.47M
Total liab 693.14M 595.44M 584.81M 680.88M 798.40M
Total stockholder equity 373.37M 124.35M 87.92M 100.70M 101.92M
Deferred long term liab - - - - -
Other current liab 11.59M - 3.25M 5.61M 15.34M
Common stock 662.85M - 467.35M 475.42M 500.88M
Capital stock 662.85M 469.33M 467.35M 475.42M 500.88M
Retained earnings -299.67600M -352.54600M -393.47100M -384.62000M -402.45300M
Other liab - - - 41.16M 52.48M
Good will 92.23M 45.85M 45.85M 45.85M 45.85M
Other assets - - 0.00000M 37.76M 47.32M
Cash 349.18M 121.85M 75.91M 167.28M 104.63M
Cash and equivalents - - - 167.28M 104.63M
Total current liabilities 330.18M 292.88M 226.39M 274.99M 281.91M
Current deferred revenue - - - - -
Net debt -6.25100M 170.64M 258.60M 216.69M 432.22M
Short term debt 19.85M - 19.88M 19.24M 73.58M
Short long term debt 19.85M 31.09M 19.88M 19.24M 73.58M
Short long term debt total 342.93M - 334.52M 383.97M 536.85M
Other stockholder equity 16.29M - 13.09M 17.70M 15.27M
Property plant equipment - - - 388.72M 535.60M
Total current assets 451.93M 243.70M 187.14M 258.04M 224.92M
Long term investments 24.47M 24.75M 24.53M - -
Net tangible assets - - - 3.64M 9.44M
Short term investments - - - - -
Net receivables 85.17M 88.74M 91.03M 64.07M 83.54M
Long term debt 310.36M 261.39M 314.64M 364.74M 463.27M
Inventory - - - 2.70M 10.29M
Accounts payable 298.74M 241.50M 203.26M 250.14M 192.99M
Total permanent equity - - - - -
Noncontrolling interest in consolidated entity - - - - -
Temporary equity redeemable noncontrolling interests - - - - -
Accumulated other comprehensive income -6.09400M - 0.96M -7.79800M -11.76800M
Additional paid in capital - - - - -
Common stock total equity - - - - -
Preferred stock total equity - - - - -
Retained earnings total equity - - - - -
Treasury stock - - - - -
Accumulated amortization - - - - -
Non currrent assets other 33.45M 29.43M 34.98M 30.47M 32.89M
Deferred long term asset charges - - - - -
Non current assets total 614.58M 476.09M 485.59M 523.54M 675.40M
Capital lease obligations - - - - -
Long term debt total - - - 364.74M 463.27M
Breakdown 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Type yearly yearly yearly yearly yearly
Date 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Investments - -9.11100M -84.45300M 155.64M -63.73300M
Change to liabilities - - - 48.62M 15.45M
Total cashflows from investing activities -119.01600M -9.11100M -84.45300M 155.64M -63.73300M
Net borrowings 33.41M -44.53400M 18.67M -114.22900M -29.98200M
Total cash from financing activities 180.43M -87.86600M -30.92800M -191.85900M -74.83600M
Change to operating activities - - - 1.40M 11.95M
Net income 96.66M 75.21M 33.98M 69.55M 11.50M
Change in cash 226.62M 46.66M -92.09700M 62.65M -75.32900M
Begin period cash flow 122.56M 75.18M 167.28M 104.63M 179.96M
End period cash flow 349.18M 121.85M 75.18M 167.28M 104.63M
Total cash from operating activities 165.21M 143.64M 23.28M 98.71M 63.42M
Issuance of capital stock 191.52M - - - -
Depreciation 37.25M 33.34M 32.59M 32.12M 38.57M
Other cashflows from investing activities 1.63M 3.37M 44.96M 257.27M 5.79M
Dividends paid 41.70M -40.02000M -40.43200M 42.55M 42.99M
Change to inventory - - - - -
Change to account receivables 18.56M -3.58300M -29.20000M 4.04M -13.76500M
Sale purchase of stock - 0.00000M -11.05600M -35.02300M -
Other cashflows from financing activities - -3.31200M 1.89M 1.31M 0.48M
Change to netincome - - - -57.02500M -0.28300M
Capital expenditures 101.81M 41.95M 129.41M 101.63M 69.52M
Change receivables - - - - -
Cash flows other operating - - - - -
Exchange rate changes - - - - -
Cash and cash equivalents changes - - - - -
Change in working capital 57.02M 22.85M -41.19500M 54.06M 13.63M
Stock based compensation 0.70M 1.89M 4.20M 2.64M 3.57M
Other non cash items -17.84600M -13.50600M -10.30700M -59.61900M -10.45900M
Free cash flow 63.40M 101.69M -106.12900M -2.91500M -6.09900M

Peer Comparison

Sector: Healthcare Industry: Medical Care Facilities

Company Change (CAD) Price (CAD) Trailing PE (x) Forward PE (x) Price Sales TTM (x) Price to Book Value (x) Enterprise Value to Revenue (x) Enterprise Value to EBITDA (x)
EXE
Extendicare Inc		 1.02 3.32% 31.73 25.21 23.92 1.59 7.26 1.62 14.43
SIA
Sienna Senior Living Inc		 0.07 0.33% 21.01 45.94 38.17 2.23 3.17 3.57 21.90
WELL
WELL Health Technologies Corp		 -0.05 1.02% 4.83 - 13.87 0.80 1.23 1.09 9.83
DR
Medical Facilities Corporation		 -0.04 0.23% 17.45 15.57 12.94 1.18 2.87 0.92 3.64
AIDX
HealWELL AI Inc.		 -0.05 5.26% 0.90 - - 2.81 2.35 3.46 -4.9271

Reports Covered

Stock Research & News

View All

Profile

Extendicare Inc., through its subsidiaries, provides care and services for seniors in Canada. It operates through the Long-term Care, Home Health Care, and Managed Services segments. The company offers long-term care services, such as accommodation and meals, and assistance with activities of daily living and continuing care to residents; and home health care services, such as nursing care, occupational, physical and speech therapy, and assistance with daily activities, as well as management, consulting, and other services to third parties and joint ventures. It provides its services under the Extendicare, ParaMed, Extendicare Assist, and SGP Purchasing Network brands. The company was incorporated in 1968 and is based in Markham, Canada.

Extendicare Inc

3000 Steeles Avenue East, Markham, ON, Canada, L3R 4T9

Key Executives

Name Title Year Born
Dr. Michael R. Guerriere M.D., MBA CEO, Pres & Director 1964
Mr. David E. Bacon Sr. VP & CFO NA
Mr. John Toffoletto Sr. VP, Chief Legal Officer & Corp. Sec. NA
Ms. Leslie Sarauer Sr. VP & Chief HR Officer 1962
Mr. Ali Mohammad Mir VP, ParaMed Operations NA
Mr. Steve Paraskevopoulos Sr. VP of ParaMed & CTO NA
Ms. Jillian E. Fountain VP of Investor Relations NA
Ms. Lisa Pearson VP of Public Affairs NA
Ms. Elaine E. Everson VP of Corp. Devel. NA
Dr. Matthew Morgan Chief Medical Officer NA

Disclaimer - This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.